ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 118 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $86,000 | -22.5% | 59,138 | -23.9% | 0.00% | – |
| Q4 2016 | $111,000 | +20.7% | 77,752 | +47.5% | 0.00% | – |
| Q3 2016 | $92,000 | +1.1% | 52,708 | 0.0% | 0.00% | – |
| Q2 2016 | $91,000 | -12.5% | 52,708 | 0.0% | 0.00% | – |
| Q1 2016 | $104,000 | +3.0% | 52,708 | -0.1% | 0.00% | – |
| Q4 2015 | $101,000 | -2.9% | 52,787 | 0.0% | 0.00% | – |
| Q3 2015 | $104,000 | -55.9% | 52,787 | 0.0% | 0.00% | – |
| Q2 2015 | $236,000 | +24.2% | 52,787 | +25.1% | 0.00% | – |
| Q1 2015 | $190,000 | +68.1% | 42,195 | +30.4% | 0.00% | – |
| Q4 2014 | $113,000 | -16.3% | 32,356 | 0.0% | 0.00% | – |
| Q3 2014 | $135,000 | – | 32,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 7,500,000 | $34,800,000 | 2.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,983,710 | $32,404,000 | 1.08% |
| DAFNA Capital Management LLC | 189,000 | $877,000 | 0.74% |
| Lyons Wealth Management, LLC. | 56,665 | $264,000 | 0.30% |
| Telemetry Investments, L.L.C. | 110,000 | $510,000 | 0.23% |
| Callan Capital, LLC | 232,000 | $1,076,000 | 0.23% |
| OXFORD ASSET MANAGEMENT LLP | 968,446 | $4,494,000 | 0.12% |
| FEDERATED HERMES, INC. | 5,641,200 | $26,175,000 | 0.08% |
| HRT FINANCIAL LP | 31,973 | $148,000 | 0.07% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,885,551 | $157,230,000 | 0.04% |